CBT
Cabot Corporation NYSE Listed Nov 5, 1980$81.24
Mkt Cap $4.2B
52w Low $58.33
85.0% of range
52w High $85.27
50d MA $73.85
200d MA $72.48
P/E (TTM)
12.7x
EV/EBITDA
6.3x
P/B
2.4x
Debt/Equity
0.8x
ROE
19.8%
P/FCF
10.4x
RSI (14)
—
ATR (14)
—
Beta
0.83
50d MA
$73.85
200d MA
$72.48
Avg Volume
446.9K
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty carbons used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.
Two Seaport Lane · Boston, MA 02210-2019 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 1.47 | 1.61 | +9.5% | 78.93 | +5.1% | +4.4% | -1.4% | — | — | — | — |
| Feb 3, 2026 | AMC | 1.40 | 1.53 | +9.3% | 71.29 | +5.0% | +10.4% | -3.1% | -2.2% | +0.0% | +1.6% | — |
| Nov 3, 2025 | AMC | 1.68 | 1.70 | +1.2% | 65.90 | -2.8% | -7.1% | -1.3% | -1.9% | +3.6% | -0.6% | — |
| Aug 4, 2025 | AMC | 1.82 | 1.90 | +4.4% | 73.71 | +4.3% | +8.7% | -2.8% | -0.1% | +0.4% | -2.9% | — |
| May 5, 2025 | AMC | 1.85 | 1.90 | +2.7% | 77.50 | -5.2% | -6.5% | +0.7% | +1.8% | -0.5% | +2.9% | — |
| Feb 3, 2025 | AMC | 1.74 | 1.76 | +1.1% | 84.87 | +0.9% | +3.9% | -1.1% | +0.7% | -1.9% | +0.1% | — |
| Nov 4, 2024 | AMC | 1.82 | 1.80 | -1.1% | 110.09 | -2.2% | -1.1% | +7.5% | -0.3% | -1.4% | +1.3% | — |
| Aug 5, 2024 | AMC | 1.72 | 1.92 | +11.6% | 86.96 | +9.1% | +16.4% | -4.5% | +0.6% | -1.1% | -1.0% | — |
| May 6, 2024 | AMC | 1.66 | 1.78 | +7.2% | 95.94 | +4.7% | +5.3% | +0.0% | +0.8% | +0.1% | +0.3% | — |
| Feb 5, 2024 | AMC | 1.50 | 1.56 | +4.0% | 71.14 | +0.9% | +7.9% | +1.1% | +3.2% | -0.3% | +2.4% | — |
| Nov 6, 2023 | AMC | 1.48 | 1.65 | +11.5% | 66.28 | +8.3% | +8.3% | -0.6% | +1.6% | +2.6% | -0.4% | — |
| Aug 7, 2023 | AMC | 1.50 | 1.42 | -5.3% | 69.34 | -6.5% | +1.8% | -0.4% | +1.2% | +0.5% | -0.2% | — |
| May 8, 2023 | AMC | 1.31 | 1.33 | +1.5% | 70.55 | -2.4% | -3.5% | +1.1% | +0.1% | +0.3% | +0.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5 | UBS | Maintains | Neutral → Neutral | — | $78.73 | $77.91 | -1.0% | -3.1% | -2.2% | +0.0% | +1.6% | +0.2% |
| Feb 5 | Mizuho | Downgrade | Outperform → Neutral | — | $78.73 | $77.91 | -1.0% | -3.1% | -2.2% | +0.0% | +1.6% | +0.2% |
| Jan 12 | UBS | Maintains | Neutral → Neutral | — | $72.83 | $72.85 | +0.0% | +0.3% | -1.9% | +1.5% | +1.1% | -3.6% |
| Dec 18 | Mizuho | Maintains | Outperform → Outperform | — | $67.53 | $68.05 | +0.8% | -0.2% | -1.9% | -0.7% | -0.4% | +1.1% |
| Nov 28 | JP Morgan | Maintains | Underweight → Underweight | — | $63.80 | $63.02 | -1.2% | -1.9% | +1.2% | +1.0% | +0.9% | -0.7% |
| Nov 17 | Mizuho | Maintains | Outperform → Outperform | — | $61.60 | $61.54 | -0.1% | -3.5% | +1.3% | -0.8% | -1.8% | +5.1% |
| Nov 5 | UBS | Maintains | Neutral → Neutral | — | $61.24 | $61.35 | +0.2% | -1.3% | -1.9% | +3.6% | -0.6% | +0.5% |
| Oct 3 | Mizuho | Maintains | Outperform → Outperform | — | $75.60 | $75.34 | -0.3% | -0.6% | +0.4% | -2.8% | -0.5% | -2.5% |
| Aug 5 | UBS | Maintains | Neutral → Neutral | — | $73.71 | $76.89 | +4.3% | +8.7% | -2.8% | -0.1% | +0.4% | -2.9% |
| Apr 7 | UBS | Maintains | Neutral → Neutral | — | $78.27 | $75.99 | -2.9% | -2.4% | -2.1% | +8.1% | -4.4% | +2.7% |
| Feb 21 | JP Morgan | Maintains | Underweight → Underweight | — | $85.51 | $86.25 | +0.9% | -1.2% | +0.5% | +2.5% | -0.4% | -1.4% |
| Jan 7 | Mizuho | Maintains | Outperform → Outperform | — | $88.73 | $88.53 | -0.2% | -0.0% | -1.1% | -1.1% | +3.0% | +0.0% |
| Nov 11 | JP Morgan | Downgrade | Neutral → Underweight | — | $114.99 | $114.58 | -0.4% | +1.3% | -3.4% | -1.4% | -1.6% | -0.3% |
| Nov 5 | Mizuho | Maintains | Outperform → Outperform | — | $110.09 | $107.67 | -2.2% | -1.1% | +7.5% | -0.3% | -1.4% | +1.3% |
| Aug 7 | JP Morgan | Maintains | Neutral → Neutral | — | $101.20 | $102.89 | +1.7% | -4.5% | +0.6% | -1.1% | -1.0% | -0.2% |
| Aug 6 | UBS | Maintains | Neutral → Neutral | — | $86.96 | $94.85 | +9.1% | +16.4% | -4.5% | +0.6% | -1.1% | -1.0% |
| May 7 | Mizuho | Maintains | Buy → Buy | — | $95.94 | $100.48 | +4.7% | +5.3% | +0.0% | +0.8% | +0.1% | +0.3% |
| May 7 | UBS | Maintains | Neutral → Neutral | — | $95.94 | $100.48 | +4.7% | +5.3% | +0.0% | +0.8% | +0.1% | +0.3% |
| Apr 18 | Deutsche Bank | Downgrade | Buy → Hold | — | $91.93 | $91.19 | -0.8% | -1.3% | +1.5% | +0.8% | +0.7% | +0.0% |
| Jan 8 | UBS | Downgrade | Buy → Neutral | — | $77.51 | $76.35 | -1.5% | -0.3% | -1.6% | +1.1% | -0.9% | +0.1% |
| Dec 14 | UBS | Maintains | Buy → Buy | — | $79.91 | $80.80 | +1.1% | +2.3% | -0.0% | +1.1% | +1.9% | -0.7% |
| Nov 7 | UBS | Maintains | Buy → Buy | — | $66.28 | $71.77 | +8.3% | +8.3% | -0.6% | +1.6% | +2.6% | -0.4% |
| Aug 11 | JP Morgan | Maintains | Neutral → Neutral | — | $71.12 | $70.95 | -0.2% | +0.5% | -0.2% | -2.3% | -1.7% | +1.7% |
| Aug 8 | Credit Suisse | Maintains | Outperform → Outperform | — | $69.34 | $64.85 | -6.5% | +1.8% | -0.4% | +1.2% | +0.5% | -0.2% |
| Jun 20 | Loop Capital | Maintains | Buy → Buy | — | $68.55 | $68.06 | -0.7% | -2.6% | -0.6% | -1.1% | -2.6% | +1.0% |
| Jun 6 | JP Morgan | Downgrade | Overweight → Neutral | — | $73.69 | $69.98 | -5.0% | -0.0% | +2.8% | -1.4% | -1.7% | -0.1% |
| May 18 | Deutsche Bank | Maintains | Buy → Buy | — | $69.06 | $68.94 | -0.2% | +1.7% | +1.0% | +1.8% | -1.3% | -1.7% |
| May 9 | Credit Suisse | Maintains | Outperform → Outperform | — | $70.55 | $68.88 | -2.4% | -3.5% | +1.1% | +0.1% | +0.3% | +0.3% |
| Mar 13 | Credit Suisse | Maintains | Outperform → Outperform | — | $74.31 | $72.97 | -1.8% | -1.0% | +3.0% | -4.2% | +2.1% | -3.2% |
| Feb 13 | Loop Capital | Maintains | Buy → Buy | — | $74.03 | $75.99 | +2.6% | +6.4% | -0.2% | +0.8% | +0.7% | +0.3% |
| Feb 13 | JP Morgan | Maintains | Overweight → Overweight | — | $74.03 | $75.99 | +2.6% | +6.4% | -0.2% | +0.8% | +0.7% | +0.3% |
| Nov 16 | Deutsche Bank | Upgrade | Hold → Buy | — | $72.75 | $73.64 | +1.2% | -1.7% | -1.2% | +2.2% | -1.0% | +3.0% |
| May 17 | Deutsche Bank | Maintains | Hold → Hold | — | $68.81 | $70.39 | +2.3% | +5.0% | -2.4% | -1.2% | -0.7% | +1.1% |
| Jan 4 | UBS | Maintains | Buy → Buy | — | $57.10 | $57.18 | +0.1% | +2.4% | -0.8% | +0.0% | +0.9% | -0.5% |
| Dec 3 | Barclays | Maintains | Overweight → Overweight | — | $53.48 | $53.71 | +0.4% | +3.7% | +1.0% | +0.1% | +0.6% | -1.1% |
| Jul 23 | JP Morgan | Upgrade | Neutral → Overweight | — | $51.79 | $53.68 | +3.6% | +3.4% | +1.2% | -1.1% | +0.7% | +2.0% |
| Jul 1 | Loop Capital | Upgrade | Hold → Buy | — | $56.93 | $58.89 | +3.4% | +2.4% | -0.7% | -1.4% | +1.9% | -2.7% |
| May 5 | Northcoast Research | Upgrade | Neutral → Buy | — | $57.40 | $58.70 | +2.3% | +6.1% | +3.3% | -0.9% | -1.4% | +0.1% |
| Nov 5 | UBS | Maintains | Buy → Buy | — | $38.66 | $39.28 | +1.6% | +6.9% | -0.3% | +4.1% | +0.7% | -3.8% |
| Jul 27 | JP Morgan | Downgrade | Overweight → Neutral | — | $38.25 | $37.20 | -2.7% | +1.4% | -2.9% | +2.6% | -4.1% | -1.6% |
| Jun 19 | UBS | Maintains | Buy → Buy | — | $37.31 | $38.06 | +2.0% | -0.4% | -1.3% | +1.1% | -3.8% | +2.0% |
| May 12 | UBS | Maintains | Buy → Buy | — | $31.84 | $31.54 | -0.9% | -7.4% | -4.4% | +2.0% | +1.3% | +12.5% |
| Apr 16 | Deutsche Bank | Maintains | Hold → Hold | — | $29.10 | $28.94 | -0.5% | -2.8% | +5.4% | -2.3% | -2.3% | +2.7% |
| Apr 3 | JP Morgan | Upgrade | Neutral → Overweight | — | $25.96 | $27.80 | +7.1% | +0.0% | +7.5% | -0.2% | +4.9% | +4.8% |
| Mar 31 | SunTrust Robinson Humphrey | Maintains | Buy → Buy | — | $26.25 | $26.01 | -0.9% | -0.5% | +1.4% | -2.0% | +0.0% | +7.5% |
| Mar 23 | UBS | Maintains | Buy → Buy | — | $21.08 | $21.13 | +0.2% | +4.1% | +10.8% | +7.6% | +2.2% | -6.3% |
| Feb 7 | UBS | Upgrade | Neutral → Buy | — | $42.34 | $43.67 | +3.1% | -1.1% | -0.1% | +2.6% | +2.0% | -1.5% |
| Nov 6 | JP Morgan | Downgrade | Overweight → Neutral | — | $49.93 | $49.18 | -1.5% | -3.7% | +3.4% | +1.0% | -1.5% | -0.3% |
| Oct 16 | Baird | Downgrade | Outperform → Neutral | — | $43.87 | $42.60 | -2.9% | -1.4% | +1.3% | -0.1% | +0.5% | +1.1% |
| Oct 10 | UBS | Maintains | Neutral → Neutral | — | $42.71 | $42.89 | +0.4% | -0.1% | +4.3% | -1.9% | +0.5% | -1.4% |
No insider trades available.
8-K · 2.02
!! High
Cabot Corporation -- 8-K 2.02: Earnings Results
Cabot Corporation reported Q2 fiscal 2026 earnings on May 5, 2026, providing investors with updated financial performance metrics and operational results for the quarter ended March 31.
May 5
8-K
Unknown — 8-K Filing
I cannot provide a meaningful analysis as the filing appears to be incomplete technical XBRL metadata without substantive disclosure content regarding CBT's business developments or financial changes.
Mar 17
8-K
Cabot Corporation -- 8-K Filing
Cabot Corporation's Performance Chemicals segment delivered 7% EBIT growth year-over-year in Q1 fiscal 2026, driven by strong momentum in its Battery Materials product line.
Feb 3
Data updated apr 25, 2026 12:09am
· Source: massive.com